Location History:
- Scotch Plains, NJ (US) (2016 - 2021)
- Brighton, MA (US) (2019 - 2021)
- West Roxbury, MA (US) (2020 - 2024)
- Roxbury, MA (US) (2024)
Company Filing History:
23 out of 2,405 
2 out of 2 
1 out of 229 Years Active: 2016-2025
Title: **Derun Li: Innovator in Arginase Inhibition**
Introduction
Derun Li is a prominent inventor based in West Roxbury, MA, with a remarkable portfolio of 20 patents. His work primarily focuses on developing innovative solutions in the field of pharmaceuticals, particularly concerning arginase inhibition, which holds potential in treating various diseases.
Latest Patents
Among his latest innovations are patents related to arginase inhibitors. These patents describe compounds of Formula (I) and their pharmaceutically acceptable salts, which function as arginase inhibitors. They aim to prevent, treat, or act as remedial agents for diseases associated with arginase, showcasing Derun's commitment to advancing medical science and improving patient outcomes.
Career Highlights
Derun Li has made significant contributions to the pharmaceutical industry through his work with renowned companies such as Merck Sharp & Dohme Corporation and Mochida Pharmaceutical Co., Ltd. His expertise in drug development and innovation has established him as a critical figure within the realm of pharmaceuticals.
Collaborations
Throughout his career, Derun has collaborated with several talented individuals, including Hongjun Zhang and Yongxin Han. These partnerships have fostered an environment of innovation, allowing for the successful development of various therapeutic agents aimed at combating arginase-related diseases.
Conclusion
Derun Li's dedication to innovation, evidenced by his extensive patent portfolio and impactful collaborations, underscores his pivotal role in the advancement of pharmaceutical solutions. His work continues to pave the way for new treatments, illustrating the power of innovation in improving health outcomes.